Neuropathy associated with prediabetes: What is new in 2007?

Current Diabetes Reports

Volumn 7, Issue 6, 2007, Pages 420-424

  Singleton, J Rob ^a   Smith, A Gordon ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN SENSITIZING AGENT; METFORMIN;

AUTONOMIC DYSFUNCTION; AXONAL INJURY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIET; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; EXERCISE; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; METABOLIC SYNDROME X; NERVE REGENERATION; NEUROPATHIC PAIN; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SYMPTOM;

DIABETIC NEUROPATHIES; GLUCOSE INTOLERANCE; HUMANS; METABOLIC SYNDROME X; PREDIABETIC STATE; RISK FACTORS;

EID: 37349105692     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-007-0070-y     Document Type: Review

References (45)

1. Gregg EW, Sorlie P, Paulose-Ram R, et al.: Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care 2004, 27:1591-1597.
2. Dyck PJ, Oviatt KF, Lambert EH: Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol 1981, 10:222-226.
3. Holland NR, Crawford TO, Hauer P, et al.: Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol 1998, 44:47-59.
4. Gorson KC, Ropper AH: Idiopathic small fiber neuropathy. Acta Neurol Scand 1995, 92:376-382.
5. Ellenberg M: Diabetic complications without manifest diabetes: complications as presenting clinical symptoms. JAMA 1963, 183:118-122.
6. Dyck PJ, Kratz JM, Karnes JL, et al.: The prevalence by staged severity of various types of diabetic neuropathy, retinopathy and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993, 43:817-824.
7. Dyck PJ, Davies JL, Wilson DM, et al.: Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care 1999, 22:1479-1486.
8. Thomas PK: Classification, differential diagnosis, and staging of diabetic peripheral neuropathy. Diabetes 1997, 46(suppl 2):S54-S57.
9. Singleton JR, Smith AG, Bromberg MB: Painful sensory neuropathy associated with impaired glucose tolerance. Muscle Nerve 2001, 24:1225-1228.
10. Sumner CJ, Sheth S, Griffin JW, et al.: The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003, 60:108-111.
11. Smith AG, Tripp C, Singleton JR: Skin biopsy findings in patients with neuropathy associated with diabetes and impaired glucose tolerance. Neurology 2001, 57:1701-1704.
12. Smith AG, Howard JR, Kroll R, et al.: The reliability of skin biopsy with measurement of intraepidermal nerve fiber density. J Neurol Sci 2005, 228:65-69.
13. Gibbons CH, Griffin JW, Polydefkis M, et al.: The utility of skin biopsy for prediction of progression in suspected small fiber neuropathy. Neurology 2006,. 66:256-258.
14. Franklin GM, Kahn LB, Marshall JA, Hamman RF: Sensory neuropathy in non-insulin-dependent diabetes mellitus. The San Luis Valley Diabetes Study. Am J Epidemiol 1990, 131:633-643.
15. de Neeling JN, Beks PJ, Bertelsmann FW, et al.: Peripheral somatic nerve function in relation to glucose tolerance in an elderly Caucasian population: the Hoorn study. Diabet Med 1996, 13:960-966.
16. Eriksson KF, Nilsson H, Lindgärde F, et al.: Diabetes mellitus but not impaired glucose tolerance is associated with dysfunction in peripheral nerves. Diabet Med 1994, 11:279-285.
17. Fujimoto WY, Bergstrom RW, Boyko EJ, et al.: Diabetes and diabetes risk factors in second and third-generation Japanese Americans in Seattle. Diabetes Res Clin Pract 1994, 24(suppl):S43-S52.
18. Suzuki K: Neurological disorders associated with impaired glucose tolerance. Nippon Rinsho 1996, 54:2704-2708.
19. Hughes RA, Umapathi T, Gray IA, et al.: A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy. Brain 2004, 127(Pt 8):1723-1730.
20. Smith AG, Singleton JR: The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy. Arch Intern Med 2004, 164:1021-1025.
21. Harris MI, Flegal KM, Cowie CC, et al.: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. Diabetes Care 1999, 21:518-524.
22. Novella SP, Inzucchi SE, Goldstein JM: The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve 2001, 24:1229-1231.
23. Dyck PJ, Klein CJ, Weigand SD: Does impaired glucose metabolism cause polyneuropathy? Review of previous studies and design of a prospective controlled population-based study. Muscle Nerve 2007, Jul 11; [Epub ahead of print].
24. Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial [no authors listed]. Ann Neurol 1995, 38:869-880.
25. Navaro X, Sutherland DE, Kennedy WR: Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol 1997, 42:727-736.
26. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. Diabetes Prevention Program Research Group [no authors listed]. New Engl J Med 2002, 346:393-403.
27. Tuomilehto J, Lindstrom J, Eriksson JG, et al.: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343-1350.
28. Smith AG, Russell J, Feldman EL, et al.: Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 2006, 29:1294-1299.
29. Polydefkis M, Hauer P, Sheth S, et al.: The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain 2004, 127(Pt 7):1606-1615.
30. Singleton JR, Bixby B, Feldman EL, et al.: Diet and exercise counseling alone does not prevent long term neuropathy progression in IGT neuropathy [abstract]. Neurology 2007, 68:A410.
31. Reaven GM: Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
32. Bonora E, Keichl S, Oberhollenzer F, et al.: Impaired glucose tolerance, type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study. Diabetologia 2000, 42:156-164.
33. Dormandy J, Heeck L, Vig S: Predictors of early disease in the lower limbs. Semin Vasc Surg 1999, 12:109-117.
34. McLaughlin T, Reaven G: Insulin resistance and hypertension: patients in double jeopardy for cardiovascular disease. Geriatrics 2000, 55:28-35.
35. Kahn R, Buse J, Ferrannini E, Stern M: The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005, 28:2289-2304.
36. Rose K, Singleton JR, Smith AG: Increased prevalence of metabolic syndrome in peripheral neuropathy [abstract]. Neurology 2006, 65:S27.006.
37. Costa LA, Canani LH, Lisboa HR, et al.: Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in type 2 diabetes. Diabet Med 2004, 21:252-255.
38. Tesfaye S, Chaturvedi N, Eaton SE, et al.: Vascular risk factors and diabetic neuropathy. N Engl J Med 2005, 352:341-350.
39. Gaede P, Vedel P, Larsen N, et al.: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003, 348:383-393.
40. Bradley DF, Smith AG, Wade J, Singleton JR: Comparative evaluation of timed vibration detection as a measure of diabetic peripheral neuropathy [abstract]. Neurology 2007, 68(suppl 1):A71.
41. Singleton JR, Smith AG, Russell J, Feldman EL: Polyneuropthy with impaired glucose tolerance: implications for diagnosis and therapy. Curr Treat Options Neurol 2005, 7:33-42.
42. Vincent AM, McLean LL, Backus C, Feldman EL: Short-term hyperglycemia produces oxidative damage and apoptosis in neurons. FASEB J 2005, 19:638-640.
43. Ziegler D, Nowak H, Kempler P, et al.: Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 2004, 21:114-121.
44. Ziegler D, Ametov A, Barinov A, et al.: Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 2006, 29:2365-2370.
45. Zeigler D: Management of painful diabetic neuropathy: what is new or in the pipeline for 2007? Curr Diab Rep 2007, 7:409-415.